Assessment of Plasma Ghrelin Levels in Patients With Pancreatic Cancer
The primary outcome measure for this study is plasma ghrelin level, and the two primary
comparison are:
- Patients with cachexia versus patients without cachexia
- Patients with cachexia versus healthy controls
Observational
Observational Model: Case Control, Time Perspective: Retrospective
To evaluate plasma ghrelin levels in patients with pancreatic cancer and compare with age matched controls
prior to treatment
No
J Marc Pipas, MD
Principal Investigator
Dartmouth-Hitchcock Medical Center
United States: Institutional Review Board
DMS 0405
NCT00225745
April 2004
June 2013
Name | Location |
---|---|
Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center | Lebanon, New Hampshire 03756 |